The pathogenesis of endometriosis: clues from the immunological evidence
This literature review summarizes immunological evidence, specifically impaired natural killer cell activity in endometriosis patients, questioning its role as a cause versus a consequence of the disease.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (55)
- Agents blocking the nuclear factor-kappaB pathway are effective inhibitors of endometriosis in an in vivo experimental model via openalex
- Blood biomarkers for the non-invasive diagnosis of endometriosis via openalex
- Decreased natural killer cell activity in women with endometriosis via openalex
- Endometriosis via openalex
- Endometriosis: its association with retrograde menstruation, dysmenorrhoea and tubal pathology via openalex
- Epidemiology of endometriosis via openalex
- Expression of inflammatory cytokines in serum and peritoneal fluid from patients with different stages of endometriosis via openalex
- IL15 promotes growth and invasion of endometrial stromal cells and inhibits killing activity of NK cells in endometriosis via openalex
- Impaired NK-cell-mediated cytotoxic activity and cytokine production in patients with endometriosis: a possible role for PCBs and DDE via openalex
- Increased nuclear expression of nuclear factor kappa-B p65 subunit in the eutopic endometrium and ovarian endometrioma of women with advanced stage endometriosis via openalex
- Increased uNK Progenitor Cells in Women With Endometriosis and Infertility are Associated With Low Levels of Endometrial Stem Cell Factor via openalex
- Increase in the expression of killer cell inhibitory receptors on peritoneal natural killer cells in women with endometriosis via openalex
- In vitro effect of gonadotropin-releasing hormone agonist on natural killer cell cytolysis in women with and without endometriosis via openalex
- Involvement of the nuclear factor-κB pathway in the pathogenesis of endometriosis via openalex
- Iron overload-modulated nuclear factor kappa-B activation in human endometrial stromal cells as a mechanism postulated in endometriosis pathogenesis via openalex
- Lymphocytes in endometriosis via openalex
- Modulation of NK cell lytic function by endometrial secretory factors: potential role in endometriosis via openalex
- Natural killer activity in stage III and IV endometriosis: impaired cytotoxicity and retained lymphokine responsiveness of natural killer cells via openalex
- Peritoneal Endometriosis, Due to the Menstrual Dissemination of Endometrial Tissue into the Peritoneal Cavity via openalex
- Peritoneal fluid environment in endometriosis. Clinicopathological implications via openalex
- Peritoneal natural killer cytotoxicity and CD25+ CD3+ lymphocyte subpopulation are decreased in women with stage III-IV endometriosis via openalex
- Platelet-derived TGF-β1 mediates the down-modulation of NKG2D expression and may be responsible for impaired natural killer (NK) cytotoxicity in women with endometriosis via openalex
- Recombinant interleukin-2 corrects in vitro the immunological defect of endometriosis via openalex
- Relationship between 17-beta-estradiol and prolactin in the regulation of natural killer cell activity during progression of endometriosis via openalex
- Retrograde menstruation in healthy women and in patients with endometriosis via openalex
- Role of eutopic endometrium in pelvic endometriosis via openalex
- Role of natural killer cell activity in the pathogenesis of endometriosis via openalex
- Serum and peritoneal fluid levels of interleukin-6 and interleukin-37 as biomarkers for endometriosis via openalex
- Structural and molecular features of the endomyometrium in endometriosis and adenomyosis via openalex
- Suppression of natural killer cell activity by sera from patients with endometriosis via openalex
- The endometrial immune environment of women with endometriosis via openalex
- W2417327597 via openalex
- W2617005810 via openalex
- W2768639020 via openalex
- W2788578140 via openalex
- W2802451887 via openalex
- W2885605094 via openalex
- W2886501956 via openalex
- W2923349683 via openalex
- W3093414444 via openalex
- W141728048 via openalex
- W4211081176 via openalex
- W4236974660 via openalex
- W11141567 via openalex
- W2087128527 via openalex
- W2072724311 via openalex
- W2093627672 via openalex
- W2097501793 via openalex
- W2064981157 via openalex
- W2129959170 via openalex
- W2149000495 via openalex
- W2159228424 via openalex
- W1996123579 via openalex
- W2409202770 via openalex
- W1994925063 via openalex
Cited by (7)
- Advances in the diagnosis and management of endometriosis: A comprehensive review 2025
- Advances in the Diagnosis and Management of Endometriosis: A Comprehensive Review 2024
- Dimethyl Fumarate Ameliorates the Endometriosis Through Anti‐Inflammatory and Anti‐Proliferation Mechanisms In Vitro and In Vivo 2024
- Immune сheckpoints in the context of external genital endometriosis 2024
- Endometrial Determinism of Endometriosis: An Unnecessary Adjunct to Retrograde Menstruation 2024
- Endometriosis: state of art 2023
- Genetics and Inflammation in Endometriosis: Improving Knowledge for Development of New Pharmacological Strategies 2021
Source provenance
- europepmc
- last seen: 2026-10-19T06:17:24.038039+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:31:02.603774+00:00